Back to Search
MADHU KRIS, M.D.
M.D.
Gastroenterology Physician
NPI: 1427112366IndividualAccepts Medicare
Specialties, Licenses & Credentials
Gastroenterology PhysicianPrimary
Internal Medicine — Gastroenterology
Code: 207RG0100X
A 417350(CA)
Education
OTHER
Class of 1976
Research & Publications (20)
Foreword; challenging the 'one-size-fits-all' approach of chemotherapy and radiotherapy for patients with non-small cell lung cancer.
PMID 18513578·Lung Cancer·2008
8-other
Systemic therapy of bronchioloalveolar carcinoma: results of the first IASLC/ASCO consensus conference on bronchioloalveolar carcinoma.
PMID 17409999·J Thorac Oncol·2006
4-observational
Consensus proposals for the prevention of acute and delayed vomiting and nausea following high-emetic-risk chemotherapy.
PMID 15565277·Support Care Cancer·2005
6-review
How today's developments in the treatment of non-small cell lung cancer will change tomorrow's standards of care.
PMID 16272456·Oncologist·2005
8-other
Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial.
PMID 14570950·JAMA·2003
3-trial
Docetaxel (Taxotere) in the treatment of non-small cell lung cancer: an international update.
PMID 11284618·Semin Oncol·2001
8-other
A phase I trial of SJG-136 (NSC#694501) in advanced solid tumors.
PMID 19672598·Cancer Chemother Pharmacol·2010
3-trial
Analysis of GD2/GM2 synthase mRNA as a biomarker for small cell lung cancer.
PMID 19457569·Lung Cancer·2010
3-trial
Evaluating variability in tumor measurements from same-day repeat CT scans of patients with non-small cell lung cancer.
PMID 19561260·Radiology·2009
8-other
Morphologic features of adenocarcinoma of the lung predictive of response to the epidermal growth factor receptor kinase inhibitors erlotinib and gefitinib.
PMID 19260752·Arch Pathol Lab Med·2009
8-other
WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis.
PMID 19576624·Cell·2009
7-preclinical
Randomized phase II study of pulse erlotinib before or after carboplatin and paclitaxel in current or former smokers with advanced non-small-cell lung cancer.
PMID 19047285·J Clin Oncol·2009
3-trial
Gemcitabine nephrotoxicity and hemolytic uremic syndrome: report of 29 cases from a single institution.
PMID 19203505·Clin Nephrol·2009
8-other
Clinical cancer advances 2008: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
PMID 19103723·J Clin Oncol·2009
8-other
Antiemesis. Clinical Practice Guidelines in Oncology.
PMID 19460282·J Natl Compr Canc Netw·2009
6-review
Safety and pharmacokinetic trial of docetaxel plus an Astragalus-based herbal formula for non-small cell lung cancer patients.
PMID 19421753·Cancer Chemother Pharmacol·2009
3-trial
DNA damage and repair capacity in patients with lung cancer: prediction of multiple primary tumors.
PMID 18640936·J Clin Oncol·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 750 W OLIVE AVE, SUITE 106
MERCED, CA 95348 - Phone
- (209) 384-3115
Quick Facts
- NPI
- 1427112366
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 50
- Publications
- 20
Are you this provider?
Claim Your Profile